Authors:
BALLESTEROS M
LASKY T
NASH D
MAGDER L
KOSKI CL
CHEHRENAMA M
Citation: M. Ballesteros et al., GUILLAIN-BARRE-SYNDROME INCIDENCE BASED ON HOSPITAL DISCHARGE DATA, The Journal of infectious diseases, 178(4), 1998, pp. 1228-1228
Citation: T. Lasky et L. Magder, HEPATOCELLULAR-CARCINOMA P53 G-GREATER-THAN-T TRANSVERSIONS AT CODON-249 - THE FINGERPRINT OF AFLATOXIN EXPOSURE, Environmental health perspectives, 105(4), 1997, pp. 392-397
Authors:
LASKY T
MAGDER L
KOSKI C
STOLLEY P
BALLESTEROS M
NASH D
TERRACCIANO G
CHEN R
SCHONBERGER L
Citation: T. Lasky et al., ASSOCIATION OF GUILLAIN-BARRE-SYNDROME WITH 1992-93 AND 1993-94 INFLUENZA VACCINES, American journal of epidemiology, 145(11), 1997, pp. 227-227
Citation: T. Lasky et E. Silbergeld, P53 MUTATIONS ASSOCIATED WITH BREAST, COLORECTAL, LIVER, LUNG, AND OVARIAN CANCERS, Environmental health perspectives, 104(12), 1996, pp. 1324-1331
Citation: Pd. Stolley et T. Lasky, MALARIA THERAPY FOR NEUROSYPHILIS - REPLY, JAMA, the journal of the American Medical Association, 271(5), 1994, pp. 348-348